Atrial Fibrillation Research
Published Online: Tuesday, January 14, 2014
Chris Cannon, MD, FACC, discusses 3 research papers on atrial fibrillation in this video produced by the American College of Cardiology.
Digoxin increases risk of death in patients with newly diagnosed atrial fibrillation.
Researchers evaluated more than 2 decades of evidence on atrial fibrillation patients taking vitamin K antagonists.
Researchers evaluated the risk of cardiovascular outcomes in atrial fibrillation patients with a history of falls.